>>> RCPT shoould trade higher : on Gilead & Teva interest Two rivals, Israeli generic drug group Teva Pharmaceutical Industries (NASDAQ:TEVA) and US company Gilead Sciences (NASDAQ:GILD), are also understood to have proposed offering $280 per share for Receptos, which has a market capitalisation of $5.1bn.